Our research confirms that the miR-454-3p/WTX/TGF-β2 signaling axis regulates the occurrence and development of HCC, providing new strategies and targets for the diagnosis and treatment of HCC. The gene discussed is TGFB2; the disease is hepatocellular carcinoma.